ESC Premium Access

Vascular degeneration and restoration

Event: ESC CONGRESS 2017
Topic: Angiogenesis
Session type: Moderated Posters
Date: 26 August 2017
Time: 12:35 - 13:25

Congress Session

7 presentations in this session

Ninjurin1 is a novel factor for vascular maturation and mediates the blood flow recovery in the hind limb ischemia.

Speaker: Mr A. Minoshima (Asahikawa, JP)

Endothelial cell-specific expression of Angiopoietin-2 leads to reduced thrombus resolution

Speaker: Doctor L. Hobohm (Mainz, DE)

Hyperglycemia potentiates the TGFbeta-induced endothelial to mesenchymal transition

Speaker: Doctor E. Pardali (Muenster, DE)

A novel protein Senescence-associated glycoprotein (SAGP) is involved in the vessel homeostasis in murine hind limb ischemia model.

Speaker: Doctor M. Suda (Niigata, JP)

The pro-angiogenic effect of coronary serum after myocardial infarction on microvascular obstruction repair. Role of hypoxia-inducible factor-1A

Speaker: Mr C. Rios Navarro (Valencia, ES)

Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies

Speaker: Doctor J. Johansson (San Francisco, US)

Artificial exosomes for post-ischemic vascular regeneration.

Speaker: Doctor S. Aday (Bristol, GB)

7 speakers from this session

Mr Akiho Minoshima

Asahikawa Medical University, Asahikawa (Japan)
0 follower

Doctor Lukas Hobohm

University Medical Center of Mainz, Mainz (Germany)
3 presentations
0 follower

Doctor Evangelia Pardali

University Hospital Münster, Muenster (Germany)
0 follower

Doctor Masayoshi Suda

Niigata University Graduate School of Medical and Dental Sciences, Niigata (Japan)
0 follower

Mr Cesar Rios Navarro

Research Foundation Hospital of Valencia (INCLIVA), Valencia (Spain)
0 follower

Doctor Jan Johansson

Resverlogix Inc., San Francisco (United States of America)
0 follower

Doctor Sezin Aday

University of Bristol, Bristol (United Kingdom of Great Britain & Northern Ireland)
0 follower

This platform is supported by

logo Novo Nordisk